Delivery Order SPE2DB20D3101-SPE2DB23FRYJ1

Award Date 9/20/23
Potential Completion Date 9/21/23
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,384.88, is for the supply of Trelegy Ellipta 200-62.5-25 60S, a respiratory medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. There is no set-aside designation for this contract. AmerisourceBergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60S, a specialized respiratory medication. The $4,127.83 firm fixed-price contract has a completion date of February 11, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,050.61, is for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, and has a period of performance through February 2, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,437.98, is for the supply of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product, with a completion date of February 26, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,934.96, is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. It is a firm fixed-price contract with a period of performance through February 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,232.63 firm-fixed-price contract is for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s, with an ultimate completion date of October 27, 2023. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,355.84 firm fixed-price contract provides the DLA with Trelegy Ellipta 100-62.5-25 60s, a respiratory medication, with a completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,381.95, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a respiratory medication. The contract has a completion date of March 14, 2025 and uses a firm fixed-price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,708.02, is for the provision of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of November 5, 2024 and is a firm fixed-price delivery order. There is no set-aside designation indicated for this award....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trelegy Ellipta 200-62.5-25 60s, a respiratory medication, with a ceiling value of $5,693.69. The contract has a period of performance through November 29, 2023 and is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRYJ1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,875.72, is for the supply of Trelegy Ellipta 200-62.5-25 60S, a respiratory medication. The contract has a completion date of September 21, 2023 and is a firm fixed-price delivery order. There is no set-aside designation, indicating the contract was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of the broader medical commodities procurement efforts under the DLA's purview to meet the healthcare needs of the military and veteran populations.

Generated 2/27/25, 10:49 AM